Bausch Health Cos (BHC) Competitors $5.76 -0.01 (-0.09%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$5.82 +0.06 (+1.04%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. VRNA, BBIO, BPMC, LEGN, ROIV, RGC, ELAN, RVMD, GRFS, and TGTXShould you be buying Bausch Health Cos stock or one of its competitors? The main competitors of Bausch Health Cos include Verona Pharma PLC American Depositary Share (VRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Legend Biotech (LEGN), Roivant Sciences (ROIV), Regencell Bioscience (RGC), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Grifols (GRFS), and TG Therapeutics (TGTX). These companies are all part of the "pharmaceutical products" industry. Bausch Health Cos vs. Its Competitors Verona Pharma PLC American Depositary Share BridgeBio Pharma Blueprint Medicines Legend Biotech Roivant Sciences Regencell Bioscience Elanco Animal Health Revolution Medicines Grifols TG Therapeutics Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) and Bausch Health Cos (NYSE:BHC) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability. Which has higher earnings & valuation, VRNA or BHC? Bausch Health Cos has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than Bausch Health Cos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma PLC American Depositary Share$42.28M212.22-$173.42M-$2.00-52.70Bausch Health Cos$9.63B0.22-$46M$0.2622.13 Do analysts prefer VRNA or BHC? Verona Pharma PLC American Depositary Share currently has a consensus target price of $109.00, suggesting a potential upside of 3.42%. Bausch Health Cos has a consensus target price of $9.00, suggesting a potential upside of 56.39%. Given Bausch Health Cos' higher probable upside, analysts plainly believe Bausch Health Cos is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15Bausch Health Cos 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is VRNA or BHC more profitable? Bausch Health Cos has a net margin of 0.99% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. Verona Pharma PLC American Depositary Share's return on equity of -23.69% beat Bausch Health Cos' return on equity.Company Net Margins Return on Equity Return on Assets Verona Pharma PLC American Depositary Share-36.62% -23.69% -9.63% Bausch Health Cos 0.99%-852.36%5.25% Which has more volatility and risk, VRNA or BHC? Verona Pharma PLC American Depositary Share has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Comparatively, Bausch Health Cos has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Do institutionals & insiders hold more shares of VRNA or BHC? 85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. Comparatively, 78.7% of Bausch Health Cos shares are held by institutional investors. 4.8% of Verona Pharma PLC American Depositary Share shares are held by company insiders. Comparatively, 8.1% of Bausch Health Cos shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor VRNA or BHC? In the previous week, Verona Pharma PLC American Depositary Share had 27 more articles in the media than Bausch Health Cos. MarketBeat recorded 34 mentions for Verona Pharma PLC American Depositary Share and 7 mentions for Bausch Health Cos. Verona Pharma PLC American Depositary Share's average media sentiment score of 0.51 beat Bausch Health Cos' score of 0.22 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verona Pharma PLC American Depositary Share 18 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch Health Cos 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBausch Health Cos beats Verona Pharma PLC American Depositary Share on 9 of the 16 factors compared between the two stocks. Get Bausch Health Cos News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CosMED IndustryMedical SectorNYSE ExchangeMarket Cap$2.13B$3.73B$5.42B$20.67BDividend YieldN/A1.27%3.99%3.66%P/E Ratio22.149.6329.9028.65Price / Sales0.2212.03372.1768.82Price / Cash0.746.4235.9423.59Price / Book14.394.028.104.32Net Income-$46M-$109.62M$3.26B$995.66M7 Day Performance0.79%4.29%0.65%1.91%1 Month Performance-14.23%17.15%2.43%-0.54%1 Year Performance4.92%34.11%27.70%14.76% Bausch Health Cos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Cos4.6277 of 5 stars$5.76-0.1%$9.00+56.4%+10.1%$2.13B$9.63B22.1420,700VRNAVerona Pharma PLC American Depositary Share1.8828 of 5 stars$105.09-0.2%$109.00+3.7%+439.7%$8.96B$42.28M0.0030Trending NewsEarnings ReportInsider TradeBBIOBridgeBio Pharma4.7221 of 5 stars$46.23-0.2%$61.50+33.0%+92.1%$8.79B$221.90M0.00400News CoverageEarnings ReportAnalyst ForecastInsider TradeOptions VolumeAnalyst RevisionBPMCBlueprint Medicines0.688 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640LEGNLegend Biotech3.8484 of 5 stars$41.51-4.3%$73.33+76.7%-32.0%$7.97B$627.24M0.002,609News CoveragePositive NewsUpcoming EarningsAnalyst RevisionROIVRoivant Sciences2.3659 of 5 stars$11.35-1.7%$16.50+45.4%+13.6%$7.85B$29.05M0.00860Upcoming EarningsRGCRegencell Bioscience0.1559 of 5 stars$13.80-8.3%N/AN/A$7.44BN/A0.0010ELANElanco Animal Health3.3481 of 5 stars$14.59-2.2%$16.17+10.8%+32.4%$7.41B$4.44B15.879,000Trending NewsEarnings ReportRVMDRevolution Medicines4.4459 of 5 stars$37.26-1.7%$68.91+84.9%-17.3%$7.06B$11.58M0.00250News CoverageEarnings ReportAnalyst ForecastGap DownGRFSGrifols3.2083 of 5 stars$10.09-0.1%$10.30+2.1%+43.3%$6.94B$7.81B0.0023,822Analyst ForecastTGTXTG Therapeutics4.0211 of 5 stars$35.99-2.5%$43.80+21.7%+39.5%$5.86B$329M153.75290Trending NewsEarnings ReportAnalyst Revision Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share Alternatives BridgeBio Pharma Alternatives Blueprint Medicines Alternatives Legend Biotech Alternatives Roivant Sciences Alternatives Regencell Bioscience Alternatives Elanco Animal Health Alternatives Revolution Medicines Alternatives Grifols Alternatives TG Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
